Kellyanne Conway called him a “man of action” after a whirlwind first week in which President Trump signed 14 Executive Orders and presidential memoranda, covering most of his key campaign issue areas from health to immigration to trade. In a series of blogs, CGD experts have been examining how some of these specific policy intentions could impact development progress. As you would expect from a group of economists, we believe in—and encourage—evidence-based policymaking, and here we look at what the existing evidence and research tell us about how likely these Executive Orders are to achieve the president’s stated goals.
CGD Policy Blogs
The New York Times reported yesterday that the Trump Administration is considering a new Executive Order that mandates cutting all funding to bodies that give full membership to the Palestinian Authority and fund abortion amongst other categories, but also suggests “at least a 40 percent overall decrease” in remaining US funding towards international organizations. The proposed cuts would do almost nothing to reduce the deficit while weakening US national security and international leadership.
Empowering Women Can Make America Great – Podcast with Amanda Glassman, Mayra Buvinic, and Charles Kenny
The scale of the turnout at the Women’s Marches across the world recently, along with President Trump’s early reinstatement of a ban on US funding for organizations that offer family planning services in foreign countries, seem to suggest an administration already at odds with an entire gender. On this week’s podcast, three CGD senior fellows weigh in on the evidence that engaging and empowering women—both at home and overseas—makes good sense, especially in an America-First strategy.
An Ambitious Goal for International Cooperation in 2017: A Global Treaty to Tackle Antimicrobial Resistance
Earlier this month, evidence emerged that a Nevada woman who died last September had contracted a superbug resistant to all 26 available antibiotics, including colistin, the drug of last resort. If left unchecked, antimicrobial resistance (AMR) could cause up to 10 million deaths a year by 2050 with a cumulative loss of $100 trillion to the global economy. The misuse of antibiotics in human medicine allows bacteria to evolve resistance to many life-saving drugs. But their excessive and inappropriate use in farm animals—which consume 70-80 percent of antibiotics sold in the United States—is another key factor accelerating drug resistance globally.
One of the questions reportedly from the Presidential transition team to the State Department was: “With so much corruption in Africa, how much of our funding is stolen?” During the nomination hearings for Rex Tillerson to be Secretary of State, Senator Rand Paul provided one answer: seventy percent of aid is “stolen off the top.” The question is a fair one to ask. The bad news is that the short answer is “we don’t know.” The better news is that the slightly longer answer is “nowhere near 70 percent.” And the best news is that if we spent more time tracking the results of aid projects, we’d have a much better idea of where corruption was a problem and if our efforts to reduce it were working.
Women account for just 15 percent of all listed inventors behind nine million patent applications across 182 countries. On current rates, we won’t achieve gender parity in inventors until around 2080. It would be in the interests of both innovative firms and the countries that house them were we to pick up the pace. Leveling the playing field for women innovators would be good for them, good for employers and good for productivity.
We analyzed participant data from 12 gender-related events and 12 randomly-selected (but similarly-sized) non-gender-related events hosted by CGD, and the evidence is very clear: men aren’t showing up for gender equality.